Company intelligence / Profile preview

CorVascular

Minneapolis, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

CorVascular has commercialized several advanced vascular diagnostic devices, most notably the FDA 510(k) cleared VasoGuard V-Series, designed for PAD/PVD detection and vascular testing; it provides multi-modal physiologic data including Doppler, PPG, and PVR, and is available for clinical use in hospitals and clinics nationwide. The company is also the US distributor for laser Doppler-based PAD-IQ and for IV-eye vein imaging.

Therapeutic areas: CardiovascularOther
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Vasamed (PAD-IQ distribution/collaboration)Novarix (IV-eye distribution)

Beyond the preview

Go deeper on CorVascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CorVascular.

Explore the full profile